États-Unis · Agences & temps réel · PR Newswire

New clinical data on lecanemab to be presented at CTAD conference 2026

Publié par PR Newswire · États-Unis il y a 1 h

STOCKHOLM, October 30, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab…

Lire l'article complet sur PR Newswire Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.prnewswire.com)

New clinical data on lecanemab to be presented at CTAD conference 2026

À lire aussi

What to consider if a company that made AI-related job cuts wants you back

Eagle Point Provides Strategic Equipment Financing to Energy Vault for Behind the Meter Power Infrastructure

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows

New clinical data on lecanemab to be presented at CTAD conference 2026

Partager

À lire aussi

What to consider if a company that made AI-related job cuts wants you back

Eagle Point Provides Strategic Equipment Financing to Energy Vault for Behind the Meter Power Infrastructure

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows